Tsun Y. Tsang, Ph.D. - Publications

2008 The Chinese University of Hong Kong, Hong Kong, Hong Kong 

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Sun J, Yeung CA, Co NN, Tsang TY, Yau E, Luo K, Wu P, Wa JC, Fung KP, Kwok TT, Liu F. Clitocine reversal of P-glycoprotein associated multi-drug resistance through down-regulation of transcription factor NF-κB in R-HepG2 cell line. Plos One. 7: e40720. PMID 22927901 DOI: 10.1371/journal.pone.0040720  0.68
2011 Sun JG, Chen CY, Luo KW, Yeung CL, Tsang TY, Huang ZZ, Wu P, Fung KP, Kwok TT, Liu FY. 3,5-Dimethyl-H-furo[3,2-g]chromen-7-one as a potential anticancer drug by inducing p53-dependent apoptosis in human hepatoma HepG2 cells. Chemotherapy. 57: 162-72. PMID 21454974 DOI: 10.1159/000326915  0.68
2011 Tsang TY, Tang WY, Chan JY, Co NN, Au Yeung CL, Yau PL, Kong SK, Fung KP, Kwok TT. P-glycoprotein enhances radiation-induced apoptotic cell death through the regulation of miR-16 and Bcl-2 expressions in hepatocellular carcinoma cells. Apoptosis : An International Journal On Programmed Cell Death. 16: 524-35. PMID 21336967 DOI: 10.1007/s10495-011-0581-5  0.68
2011 Au Yeung CL, Tsang TY, Yau PL, Kwok TT. Human papillomavirus type 16 E6 induces cervical cancer cell migration through the p53/microRNA-23b/urokinase-type plasminogen activator pathway. Oncogene. 30: 2401-10. PMID 21242962 DOI: 10.1038/onc.2010.613  0.68
2010 Au Yeung CL, Tsang WP, Tsang TY, Co NN, Yau PL, Kwok TT. HPV-16 E6 upregulation of DNMT1 through repression of tumor suppressor p53. Oncology Reports. 24: 1599-604. PMID 21042757 DOI: 10.3892/or-00001023  0.68
2010 Co NN, Tsang WP, Tsang TY, Yeung CL, Yau PL, Kong SK, Kwok TT. AF1q enhancement of gamma irradiation-induced apoptosis by up-regulation of BAD expression via NF-kappaB in human squamous carcinoma A431 cells. Oncology Reports. 24: 547-54. PMID 20596645 DOI: 10.3892/or-00000891  0.68
2009 Tsang TY, Tsang SW, Lai KP, Tsang WP, Co NN, Kwok TT. Facilitation of drug resistance development by gamma-irradiation in human cancer cells. Oncology Reports. 22: 921-6. PMID 19724874 DOI: 10.3892/or_00000518  0.68
2009 Tsang TY, Tang WY, Tsang WP, Co NN, Kong SK, Kwok TT. Mechanistic study on growth suppression and apoptosis induction by targeting hepatoma-derived growth factor in human hepatocellular carcinoma HepG2 cells. Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology. 24: 253-62. PMID 19710540 DOI: 10.1159/000233250  0.68
2008 Co NN, Tsang WP, Wong TW, Cheung HH, Tsang TY, Kong SK, Kwok TT. Oncogene AF1q enhances doxorubicin-induced apoptosis through BAD-mediated mitochondrial apoptotic pathway. Molecular Cancer Therapeutics. 7: 3160-8. PMID 18852119 DOI: 10.1158/1535-7163.MCT-08-0416  0.68
2008 Tsang TY, Tang WY, Tsang WP, Co NN, Kong SK, Kwok TT. Downregulation of hepatoma-derived growth factor activates the Bad-mediated apoptotic pathway in human cancer cells. Apoptosis : An International Journal On Programmed Cell Death. 13: 1135-47. PMID 18651222 DOI: 10.1007/s10495-008-0241-6  0.68
2007 Wong RP, Tsang WP, Chau PY, Co NN, Tsang TY, Kwok TT. p53-R273H gains new function in induction of drug resistance through down-regulation of procaspase-3. Molecular Cancer Therapeutics. 6: 1054-61. PMID 17363498 DOI: 10.1158/1535-7163.MCT-06-0336  0.68
Show low-probability matches.